Literature DB >> 7261311

Gas-chromatographic determination of disopyramide and its mono-N-dealkylated metabolite in serum with use of a nitrogen-selective detector.

J E Bredesen.   

Abstract

I describe a rapid, simple routine gas-liquid chromatographic method for simultaneous isothermal quantitation of disopyramide and its mono-N-dealkylated metabolite. The method involves one extraction step with dichloromethane, derivatization of the metabolite, and gas chromatography with an OV-17 liquid phase. Standard curves were linear over the concentration range tested (0.1-25 mg/L) and the maximum coefficient of variation was 9.2%. Quantitation of both disopyramide and its mono-N-dealkylated metabolite with the present method is less time-consuming than are gas-chromatographic methods previously described.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7261311

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  5 in total

1.  Effect of ethanol intake on disopyramide elimination by healthy volunteers.

Authors:  H Olsen; J E Bredesen; P K Lunde
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

2.  Relationship between alpha 1-acid glycoprotein and distribution of disopyramide and mono-N-dealkyldisopyramide in whole blood.

Authors:  J E Bredesen; P Kierulf
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

3.  Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide.

Authors:  J E Bredesen; P Kierulf
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

4.  Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure.

Authors:  K Landmark; J E Bredesen; E Thaulow; S Simonsen; J P Amlie
Journal:  Eur J Clin Pharmacol       Date:  1981-02       Impact factor: 2.953

5.  Plasma binding of disopyramide and mono-N-dealkyldisopyramide.

Authors:  J E Bredesen; E Pike; P K Lunde
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.